Triple

T17093459
Position Surface form Disambiguated ID Type / Status
Subject NewLink Genetics E414780 entity
Predicate developed P73 FINISHED
Object HyperAcute Lung vaccine
HyperAcute Lung vaccine is an experimental cancer immunotherapy designed to stimulate the immune system to target lung cancer cells.
 E1249868 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: HyperAcute Lung vaccine | Statement: [NewLink Genetics, developed, HyperAcute Lung vaccine]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: HyperAcute Lung vaccine
Context triple: [NewLink Genetics, developed, HyperAcute Lung vaccine]
  • A. E*Vax
    E*Vax is the stage name of Evan Mast, an American electronic musician and producer best known as one half of the duo Ratatat.
  • B. Spikevax
    Spikevax is Moderna’s mRNA-based COVID-19 vaccine used worldwide to prevent infection and severe disease caused by the SARS-CoV-2 virus.
  • C. Vaxzevria COVID-19 vaccine
    Vaxzevria COVID-19 vaccine is a viral vector coronavirus vaccine created to prevent COVID-19 infection and severe disease in adults.
  • D. Synagis
    Synagis is a monoclonal antibody medication used to help prevent serious lower respiratory tract infections caused by respiratory syncytial virus (RSV) in high-risk infants and young children.
  • E. rVSV-ZEBOV
    rVSV-ZEBOV is an experimental recombinant vesicular stomatitis virus-based vaccine developed to protect humans against infection by the Zaire strain of the Ebola virus.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: HyperAcute Lung vaccine
Triple: [NewLink Genetics, developed, HyperAcute Lung vaccine]
Generated description
HyperAcute Lung vaccine is an experimental cancer immunotherapy designed to stimulate the immune system to target lung cancer cells.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07 
Target entity: HyperAcute Lung vaccine
Target entity description: HyperAcute Lung vaccine is an experimental cancer immunotherapy designed to stimulate the immune system to target lung cancer cells.
  • A. E*Vax
    E*Vax is the stage name of Evan Mast, an American electronic musician and producer best known as one half of the duo Ratatat.
  • B. Spikevax
    Spikevax is Moderna’s mRNA-based COVID-19 vaccine used worldwide to prevent infection and severe disease caused by the SARS-CoV-2 virus.
  • C. Vaxzevria COVID-19 vaccine
    Vaxzevria COVID-19 vaccine is a viral vector coronavirus vaccine created to prevent COVID-19 infection and severe disease in adults.
  • D. Synagis
    Synagis is a monoclonal antibody medication used to help prevent serious lower respiratory tract infections caused by respiratory syncytial virus (RSV) in high-risk infants and young children.
  • E. rVSV-ZEBOV
    rVSV-ZEBOV is an experimental recombinant vesicular stomatitis virus-based vaccine developed to protect humans against infection by the Zaire strain of the Ebola virus.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d886cfc8e88190b05ba466edd35591 completed April 10, 2026, 5:12 a.m.
NER Named-entity recognition batch_69e3dbfb89348190942984037bd3bd2e completed April 18, 2026, 7:31 p.m.
NED1 Entity disambiguation (via context triple) batch_6a012eec0d5c8190806e756aae848ba2 completed May 11, 2026, 1:20 a.m.
NEDg Description generation batch_6a012f7f8b148190914b0d7cfb2d5c5c completed May 11, 2026, 1:23 a.m.
NED2 Entity disambiguation (via description) batch_6a012ffb67d4819099ec8d668cb590c9 completed May 11, 2026, 1:25 a.m.
Created at: April 10, 2026, 5:35 a.m.